Search

everythinglearnresearchcommunity

for

Search:↓

There is no significant link between metabolic syndrome and alopecia areata.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Immune cells are crucial for hair growth and preventing hair loss.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Low iron levels may be linked to some types of hair loss in women.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.